Read More Pharma Industry News Immutep taps Charles River for IMP761 LAG-3 antibody preclinical study Immutep Limited, an Australian biotech company specializing in LAG-3 immunotherapies for cancer and autoimmune diseases, has partnered with… byPallavi MadhirajuMay 29, 2023